Zvi Gur

Dr. Zvi Gur


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Nir ErdinestNir Erdinest
Nir Erdinest
MTMichael Tabi
Michael Tabi
NSNadav Shemesh
Nadav Shemesh
JCJamel Corredores
Jamel Corredores
Claudia YahalomClaudia Yahalom
Claudia Yahalom
Itay LavyItay Lavy
Itay Lavy
Objectives: This study evaluated the therapeutic potential of topical Ripasudil hydrochloride hydrate in managing various forms of corneal edema. Methods: This retrospective study included 96 patients of 72.20 ± 10.52 years, with 53 females (55.2%) who were treated with Ripasudil for corneal edema, with a mean treatment duration of 5.2 ± 2.3 months, divided into four groups: post-cataract surgery (n = 32), Fuchs endothelial corneal dystrophy (FECD; n = 29), post-Descemet membrane endothelial keratoplasty (DMEK; n = 25), and post-penetrating keratoplasty (PKP; n = 10). All patients were treated with Ripasudil, typically administered three times daily in the first week and twice daily in the following months. Clinical efficacy outcomes were assessed using changes in best-corrected visual acuity (BCVA), central corneal thickness (CCT), and endothelial cell count (ECC) with specular microscopy, anterior segment optical coherence tomography (OCT), and slit-lamp examination, while intraocular pressure (IOP) was measured using the iCare tonometer. Results: Ripasudil treatment led to a reduction in CCT and improvement in visual acuity across most groups, with minimal changes in ECC. CCT decreased by 30.44 μm (p < 0.001), 25.56 μm (p < 0.001), 8.41 μm (p = 0.05), and 6.80 μm (p > 0.1); visual acuity improved by 0.27 (p = 0.001), 0.18 (p = 0.02), 0.17 (p = 0.025), and 0.07 logMAR units (p > 0.1); and ECC changed by +7.0 (p > 0.1), 15.4 (p > 0.1), −7.6 (p > 0.1), and 2.3 cells/mm2 (p > 0.1) in the post-cataract surgery, FECD, post-DMEK, and post-PKP groups, respectively. Conclusions: No adverse events or progression of edema were recorded during the follow-up period. These findings support the role of Ripasudil as a non-invasive pharmacological approach to managing corneal edema and delaying or possibly avoiding surgical interventions, such as corneal transplantation, in selected cases.

20 July 2021 in Orbit
Verified
Journal Article
Closed access
ANAna Navarrete
Ana Navarrete
AMArie Maya
Arie Maya
SBStephanie Benshushan
Stephanie Benshushan
SOShay Ofir
Shay Ofir
YDYael Deckel
Yael Deckel
ZGZvi Gur
Zvi Gur
A 10-month-old female presented with a rapidly growing, painless mass in the right upper eyelid. Due to suspected malignancy, she underwent an urgent biopsy. Histopathological and immunohistochemical analyses revealed nodular fasciitis. Here, we describe the case and perform a literature review of orbital nodular fasciitis in the pediatric population.

9 January 2026 in Medicine
Verified
Journal Article
Open access
Nir ErdinestNir Erdinest
Nir Erdinest
MTMichael Tabi
Michael Tabi
OSOr Shmueli
Or Shmueli
YEYossi Eshel
Yossi Eshel
SGSalome Goldmann
Salome Goldmann
Itay LavyItay Lavy
Itay Lavy
This study evaluates the safety and efficacy of a novel triangular suture technique (TST) as an alternative method to scleral-fixated intraocular lens implantation in patients with intraocular lens (IOL) dislocation following cataract surgery. The aim is to assess visual outcomes, intraocular pressure (IOP) control, and complication rates over an extended follow-up period. A retrospective cohort study analyzed 43 patients (48.8% female; mean age 77.9 ± 10.3 years) who underwent scleral-supported IOL implantation using the TST. Preoperative assessments included ocular history, baseline visual acuity, and IOP. Postoperative follow-up was conducted at 6 defined intervals over 26 months. All surgeries were performed using a uniform triangular scleral suture approach with 10-0 polypropylene in a three-point support pattern. Sutures were placed 3.0 mm posterior to the limbus at 11, 7, and 3 o’clock positions (corresponding to the triangular configuration), with subconjunctival passage between designated clock-hour positions to prevent erosion and ensure proper IOL centration. Outcome measures included uncorrected visual acuity, best-corrected visual acuity, IOP, glaucoma medication requirements, and central macular thickness. Uncorrected visual acuity improved significantly from 0.92 ± 0.55 to 0.50 ± 0.40 logarithm of the minimum angle of resolution (logMAR) at 6 months ( P < .01). Best-corrected visual acuity improved significantly from 0.75 ± 0.34 to 0.36 ± 0.42 logMAR at 6 months ( P < .01) and was maintained at 0.37 ± 0.50 logMAR at 26 months ( P < .01). A transient IOP rise was observed on the first postoperative day (mean 18.14 ± 5.65 mm Hg; P < .05), with normalization thereafter. No significant complications were observed over the 24-month follow-up period. The TST provides a safe and effective alternative to conventional scleral-fixated intraocular lens fixation methods, offering significant and sustained visual improvement, minimal complications, excellent IOL stability, and stable anatomical outcomes over extended follow-up.

20 July 2026 in Ophthalmic Plastic & Reconstructive Surgery
Verified
Journal Article
Closed access
INItay Nitzan
Itay Nitzan
ZGZvi Gur
Zvi Gur
Was not provided for this article.

24 September 2026 in Frontiers in Ophthalmology
Verified
Journal Article
Open access
PDF file
INItay Nitzan
Itay Nitzan
TSTehila Shlomov
Tehila Shlomov
ZGZvi Gur
Zvi Gur
In oculoplastic surgery, real-world databases capture diagnosis and procedure codes but rarely the clinical variables that define surgical meaning: laterality, levator function, margin-reflex distance, inflammatory activity, operative intent, or the reason for revision. We propose that clinical supervision be recorded as documented clinical interpretive annotation : an explicit, written layer that defines the limits of routinely collected data before they are analyzed. “Mentorship as metadata” names the educational relationship that produces this annotation and is used throughout as a labelled metaphor, not as a claim of equivalence with formal metadata, data provenance, or research-governance documentation. Synthesizing established reporting and causal-inference frameworks with recently published oculoplastic database studies (2019–2026), we develop a three-layer model: code, phenotype, and judgment, together with a pre-analysis phenotype map that trainees and mentors can complete before a query is run. Central to this framework is the “refusal point”: a documented, pre-specified boundary at which a dataset should not be used to answer a given clinical question, co-signed by the oculoplastic mentor, the trainee or lead analyst, and a methodologist and recorded as a routine study-design deliverable. The refusal point complements the estimand and target-trial frameworks by naming the adjacent, more tempting question that the data cannot answer. It introduces no new statistical construct; its contribution is documentary, procedural, and educational, and we state explicitly what each existing framework already requires and what remains unspecified. We advance one falsifiable hypothesis: that pre-specified, co-signed refusal-point documentation increases pre-analysis reframing of research questions and improves concordance between the protocol estimand and the estimand the published conclusions can support, and we set out a prospective programme capable of refuting it. Real-world data remain valuable for utilization, trends, and rare associations, but they are not self-interpreting. Training oculoplastic surgeon-scientists to name, in writing and before analysis, the boundary between code and clinical reality may make database research more transparent, restrained, and reproducible. In oculoplastics, mentorship is the clinical annotation that turns data into evidence.

28 January 2026
Verified
Journal Article
Closed access
TSTehila Shlomov
Tehila Shlomov
INItay Nitzan
Itay Nitzan
RPRena Pollack
Rena Pollack
OZOfira Zloto
Ofira Zloto
ZGZvi Gur
Zvi Gur